Article
Defining an optimal time window to screen for hepatoblastoma in children with Beckwith‐Wiedemann syndrome
30 Sept 2018
Abstract excerpt
Patients with Beckwith-Wiedemann spectrum (BWSp) undergo quarterly alpha-fetoprotein measurement for hepatoblastoma (HB) screening up to 4 years of age, paralleling the epidemiology of nonsyndromic HB. However, specific data on the timing of HB development in BWSp are lacking. Here we compare the timing of presentation of HBs in BWSp with a control cohort of consecutive HB cases, demonstrating that halving...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
